ALUMIS INC.
For the period ended Dec 31, 2024. Filed Mar 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 19, 2025
ALMS$6.40-2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| | | | | | | |
|---|---|---|---|---|---|---|
| | Year ended December 31, | |||||
| (in thousands, except share amounts) · · 2024 · 2023 | ||||||
| Cash flows from operating activities · · | ||||||
| Net loss | | $(294,233) | | $(154,993) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | ||
| Stock-based compensation | | 19,457 | | 8,625 | ||
| Change in fair value of derivative liability | | 5,406 | | 119 | ||
| Net accretion of discounts on marketable securities | | (3,685) | | (544) | ||
| Depreciation and amortization | | 3,152 | | 1,284 | ||
| Non-cash lease expense | | 60 | | 2,010 | ||
| Loss on disposal of fixed assets | | 5 | | 266 | ||
| Write-off of deferred offering costs | | — | | 555 | ||
| Loss on abandonment of right-of-use assets | | — | | 645 | ||
| Changes in operating assets and liabilities: | | | | | ||
| Research and development prepaid expenses | | (10,763) | | 5,526 | ||
| Other prepaid expenses and other assets | | (2,870) | | (340) | ||
| Accounts payable | | 8,506 | | (642) | ||
| Research and development accrued expenses | | 18,203 | | 5,168 | ||
| Other accrued expenses and current liabilities | | 3,542 | | 2,490 | ||
| Operating lease liabilities | | (1,858) | | (144) | ||
| Net cash used in operating activities | | (255,078) | | (129,975) | ||
| Cash flows from investing activities | | | ||||
| Maturities of marketable securities | | 128,000 | | 76,250 | ||
| Purchases of marketable securities | | (240,058) | | (11,279) | ||
| Purchases of property and equipment | | (1,732) | | (4,499) | ||
| Net cash (used in) provided by investing activities | | (113,790) | | 60,472 | ||
| Cash flows from financing activities | | | ||||
| Proceeds from issuance of redeemable convertible preferred stock and derivative liability, net of offering costs | | 258,461 | | 89,778 | ||
| Proceeds from initial public offering, net of underwriter discounts and commissions and other offering costs | | | 193,316 | | | — |
| Proceeds from a private placement transaction | | | 40,000 | | | — |
| Proceeds from issuance of common stock upon exercise of stock options | | 596 | | 453 | ||
| Payments of deferred offering costs | | — | | (485) | ||
| Repurchase of unvested common stock shares issued upon early exercised stock options | | (6) | | (64) | ||
| Net cash provided by financing activities | | 492,367 | | 89,682 | ||
| Net increase in cash, cash equivalents and restricted cash | | 123,499 | | 20,179 | ||
| Cash, cash equivalents and restricted cash at beginning of period | | 47,133 | | 26,954 | ||
| Cash, cash equivalents and restricted cash at end of period | | $170,632 | | $47,133 | ||
| Supplemental disclosures: | | | ||||
| Conversion of 168,489,871 shares of redeemable convertible preferred stock upon the closing of initial public offering | | $639,237 | | $— | ||
| Settlement of derivative liability upon issuance of redeemable convertible preferred stock | | $(14,319) | | $(2,231) | ||
| Recognition of derivative liability upon issuance of redeemable convertible preferred stock | | $8,913 | | $2,112 | ||
| Vesting of early exercised stock options and unvested restricted shares of common stock | | $1,174 | | $1,944 | ||
| Right-of-use assets obtained in exchange for operating lease liabilities | | $— | | $14,255 | ||
| Property and equipment acquired through tenant improvement allowance | | $— | | $16,691 | ||
| Purchases of property and equipment in other accrued expenses and current liabilities | | $— | | $49 | ||
| Reconciliation of cash, cash equivalents and restricted cash: | | | | |||
| Cash and cash equivalents | | $169,526 | | $45,996 | ||
| Restricted cash | | — | | 113 | ||
| Restricted cash, non-current | | 1,106 | | 1,024 | ||
| Total cash, cash equivalents and restricted cash | | $170,632 | | $47,133 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.